COMP <GO>
PACS vs UNH // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
PACS Group Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: PACS 9
— UNH 6
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: PACS
LAST: $47.81 (-3.76%) • MKT CAP: $7.87B
options-implied-move
6.70%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
options-implied-move
6.74%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PACS VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PACS | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 88.57% | -47.57 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.60% | 11.47% | +13.13 | PACS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.5x | 16.4x | -0.95 | PACS | /valuation <GO> |
| Free Cash Flow Yield | 2.11% | 6.48% | -4.37 | UNH | /fcf-yield <GO> |
| Operating Margin | 5.90% | 4.82% | +1.08 | PACS | /operating-margins <GO> |
| Net Profit Margin | 3.60% | 3.14% | +0.46 | PACS | /net-margins <GO> |
| Revenue Growth (YoY) | 29.40% | 6.46% | +22.94 | PACS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.24 | 3.12 | -0.88 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | PACS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.70% | 6.74% | -0.04 | PACS | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.6 | 56.0 | +1.60 | PACS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.33 | +0.62 | PACS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.5x | 17.1x | +17.41 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.87B | $364.66B | -$356.79B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PACS REV | UNH REV | PACS GROSS % | UNH GROSS % | PACS FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.29B | $447.57B | 44.0% | 88.7% | $166.3M | $16.07B |
| FY 2024 | $4.09B | $400.28B | 44.0% | 88.3% | $183.4M | $20.70B |
| FY 2023 | $3.11B | $371.62B | 44.0% | 89.6% | -$76.3M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PACS // BETA 0.95
UNH // BETA 0.33